Skip to main content

Table 3 Adverse events reported in this study

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

 

Telbivudine

Control

P value

CK Elevation of mother, n (%)

7 (5%)

0 (0%)

0.022

Malformation induced labor, n

1

1

1.000

Abortion, n

1

2

0.575

Premature labor, n

3

2

1.000

Congenital diseases, n

1

1

1.000